Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Current Assets

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹12,480 Cr₹11,573 Cr₹9,966 Cr₹9,888 Cr₹9,075 Cr

What is the latest Net Current Assets ratio of AUROBINDO PHARMA ?

The latest Net Current Assets ratio of AUROBINDO PHARMA is ₹12,480 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹12,480 Cr
Mar2024₹11,573 Cr
Mar2023₹9,966 Cr
Mar2022₹9,888 Cr
Mar2021₹9,075 Cr

How is Net Current Assets of AUROBINDO PHARMA Trending?

Years Net Current Assets % Change
Mar2025 ₹12,480 Cr
7.84
Mar2024 ₹11,573 Cr
16.12
Mar2023 ₹9,966 Cr
0.79
Mar2022 ₹9,888 Cr
8.96
Mar2021 ₹9,075 Cr -

Compare Net Current Assets of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹75,771.2 Cr 6.4% 8.6% 17.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,855.0 Cr 2.4% 7.1% 14.6% Stock Analytics
DIVIS LABORATORIES ₹168,550.0 Cr -0.2% 3.8% 15.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,906.0 Cr 1.8% 10.9% 48.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,632.0 Cr 1% 4% 16.6% Stock Analytics
CIPLA ₹107,427.0 Cr 0.3% -0.9% -6% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

6.4%

8.6%

17.7%

SENSEX

-2.9%

-8%

5.3%


You may also like the below Video Courses